Viz: Completed Phase IIb enrollment

Kuros completed enrollment of 183 patients in an Australian and European Phase IIb trial comparing KUR-111 vs. autologous bone grafting. Baxter licensed exclusive rights to KUR-212 from Kuros in 2005...